The prediction of steady-state plasma phenobarbitone concentrations (following low-dose phenobarbitone) to refine its use as an indicator of compliance.

Documenti analoghi

• A comparison of a short half-life marker (low-dose isoniazid), a long half-life pharmacological indicator (low-dose phenobarbitone) and measurements of a controlled release 'therapeutic drug' (metoprolol, Metoros) in reflecting incomplete compliance by volunteers.
  di: Hardy, E, et al.
  Pubblicazione: (1990)
• Low-dose phenobarbitone as an indicator of compliance with drug therapy.
  di: Feely, M, et al.
  Pubblicazione: (1987)
• Measuring treatment compliance of men with non-gonococcal urethritis receiving oxytetracycline combined with low dose phenobarbitone.
  di: Bignell, C J, et al.
  Pubblicazione: (1988)
• The effect of low-dose phenobarbitone on three indices of hepatic microsomal enzyme induction.
  di: Price, D E, et al.
  Pubblicazione: (1986)
• Initial evaluation of low-dose phenobarbital as an indicator of compliance with antimalarial drug treatment.
  di: Karbwang, J., et al.
  Pubblicazione: (1998)